Tu1468 DISCOVERY AND CHARACTERIZATION OF XMAB412: A NOVEL, HIGH-AFFINITY, ANTI-TL1A X ANTI-IL23 NATIVE-LIKE BISPECIFIC ANTIBODY WITH EXTENDED HALF-LIFE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Gastroenterology 2026

View at publisher
Authors: Matthew S. Faber, Kendra N. Avery, Peter Nam, Tian Zhang, L Go, Sahak Makaryan, Viralkumar Davra, Chamitha Weeramange, Karen Balcazar, Thuy Truong, Stacie Hao, Jing Qi
+18 more Hanh Nguyen, Rumana Rashid, Rushelle Love, Juan E. Diaz, James Wieler, Katrina Bykova, 추세웅, Shelley S. Belouski, Sher Karki, Matthew Bernett, Greg L. Moore, Rena Bahjat, Jitendra Kanodia, Norman J. Barlow, Mark T. Osterman, Bassil Dahiyat, John R. Desjarlais, James A. Ernst
DOI: 10.1016/s0016-5085(26)03156-2
Cited by: 1

Fields of Study & Subjects

Immune Response and Inflammation T-cell and B-cell Immunology Psoriasis: Treatment and Pathogenesis

Publication details

Journal / source
Gastroenterology
Publisher
Elsevier BV
Volume
170
Issue
6
Pages
S–1259
Publication date
1 May 2026
Language
EN